Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on offer for subscription

14 Aug 2020 14:36

RNS Number : 2272W
Amati AIM VCT PLC
14 August 2020
 

14 August 2020

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Update on offer for subscription

The Board of Amati AIM VCT plc (the "Company") announced on 31 October 2019 that the Company had published a prospectus in connection with proposals to raise up to £25,000,000 (with an over-allotment facility to raise up to a further £20,000,000), by way of an offer for subscription (the "Offer") of new ordinary shares (the "New Shares").

The Company announced on 29 April 2020 that £25,000,000 had been raised under the Offer and that the Board had decided not to utilise the over-allotment facility at that time. However, the Company has continued to identify and make new investments, with around £11.4 million new qualifying investments being made since the start of the Company's financial year on 1 February 2020.

Having considered the current rate of investment activity, the Board is pleased to announce that the Offer has now re-opened and the Company is seeking to raise up to £20,000,000 available under the over-allotment facility. The next allotment of New Shares under the Offer is expected to be on or around 14 September 2020 and thereafter allotments will be made at the discretion of the Board. The Offer will close at 12 noon on 16 October 2020 (unless the Offer is fully subscribed before this date and/or the Board closes the Offer earlier, which it may do in its sole discretion).

The Prospectus is available at www.amatiglobal.com and https://data.fca.org.uk/#/nsm/nationalstoragemechanism and, until 30 October 2020, copies are available for collection, free of charge, from the offices of Amati Global Investors and the offices of Dickson Minto W.S. on any Business Day. Copies can also be requested by contacting Amati Global Investors on +44 (0)131 503 9115 or by email at info@amatiglobal.com.

Subscriptions can be made online at www.amatioffer.com or by completing the subscription form contained in the Prospectus.

For further information, please contact Samantha Dalby on +44 (0)131 503 9115 or email: info@amatiglobal.com

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations ((EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPEADPLFDLEEFA
Date   Source Headline
10th Apr 20188:14 amRNSDirector/PDMR Shareholding
9th Apr 20185:19 pmRNSIssue of Equity
4th Apr 20185:10 pmRNSNet Asset Value(s)
4th Apr 201811:21 amRNSCompliance with Market Abuse Regulation
3rd Apr 20189:38 amRNSTotal Voting Rights
29th Mar 20182:29 pmRNSTransaction in Own Shares
27th Mar 20183:49 pmRNSIssue of Equity
26th Mar 201811:41 amRNSNet Asset Value(s)
23rd Mar 20185:45 pmRNSTransaction in Own Shares
20th Mar 20185:23 pmRNSIssue of Equity
19th Mar 20183:15 pmRNSNet Asset Value(s)
19th Mar 20181:31 pmRNSHolding(s) in Company
13th Mar 20182:30 pmRNSTransaction in Own Shares
12th Mar 20183:07 pmRNSNet Asset Value(s)
9th Mar 20185:47 pmRNSIssue of a Supplementary Prospectus and Circular
2nd Mar 20185:03 pmRNSNet Asset Value(s)
1st Mar 201810:07 amRNSTotal Voting Rights
28th Feb 20188:02 amRNSIssue of Equity - replacement
27th Feb 20183:45 pmRNSDirector/PDMR Shareholding
27th Feb 20183:39 pmRNSIssue of Equity
26th Feb 20183:11 pmRNSNet Asset Value(s)
23rd Feb 20183:39 pmRNSTransaction in Own Shares
20th Feb 201811:00 amRNSNet Asset Value(s)
15th Feb 20182:02 pmRNSTransaction in Own Shares
12th Feb 20184:27 pmRNSNet Asset Value(s)
5th Feb 20181:46 pmRNSTransaction in Own Shares
2nd Feb 20182:38 pmRNSNet Asset Value(s)
1st Feb 20188:10 amRNSTotal Voting Rights
31st Jan 201810:07 amRNSDirector/PDMR Shareholding
30th Jan 20185:11 pmRNSIssue of Equity
29th Jan 20185:01 pmRNSNet Asset Value(s)
22nd Jan 20185:07 pmRNSNet Asset Value(s)
22nd Jan 201811:16 amRNSTransaction in Own Shares
19th Jan 201811:38 amRNSTransaction in Own Shares
18th Jan 201810:07 amRNSDirector Declaration
15th Jan 20184:53 pmRNSNet Asset Value(s)
4th Jan 20183:20 pmRNSNet Asset Value(s)
3rd Jan 20187:29 amRNSTotal Voting Rights
28th Dec 201710:26 amRNSTransaction in Own Shares
27th Dec 20177:00 amRNSNet Asset Value(s)
19th Dec 20174:39 pmRNSIssue of Equity
18th Dec 20174:15 pmRNSNet Asset Value(s)
18th Dec 201710:14 amRNSTransaction in Own Shares
11th Dec 20175:31 pmRNSNet Asset Value(s)
8th Dec 201712:25 pmRNSTransaction in Own Shares
6th Dec 201710:27 amRNSHolding(s) in Company
4th Dec 20174:22 pmRNSNet Asset Value(s)
1st Dec 20175:05 pmRNSTransaction in Own Shares
1st Dec 20179:27 amRNSTotal Voting Rights
29th Nov 201711:30 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.